CAMBRIDGE, United Kingdom, February 04, 2025--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Observed at 23:00, Monday 10 February BBC Weather in association with MeteoGroup, external All times are East Timor Time (Asia/Dili, GMT+9) unless otherwise stated.

All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection ...